BRIANSTORM - Early Identification of Patients With Brain Metastases
NCT05185557 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2023-02-03
Summary
A single arm observational study investigating the incidence of brain metastasis in patients with cancer recti and lung metastasis
Conditions
- Metastatic Rectal Adenocarcinoma
- Brain Metastases
Sponsors & Collaborators
-
Aarhus University Hospital
lead OTHER
Principal Investigators
-
Anders K Boysen, MD, PhD · Department of Oncology, Aarhus University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-16
- Primary Completion
- 2023-08-31
- Completion
- 2025-02-28
Countries
- Denmark
Study Locations
More Related Trials
-
Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma
NCT02015026 ·Status: COMPLETED
-
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
NCT04197414 ·Status: RECRUITING
-
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
NCT04358107 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Genetic and Pathological Studies of Anal Tumors
NCT00267787 ·Status: TERMINATED
-
Optical Genome Mapping in Hematological Malignancies
NCT05009537 ·Status: RECRUITING
-
Biomarker Development for Response Prediction by DNA Mutational Analysis
NCT01855061 ·Status: TERMINATED
-
Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma
NCT05889481 ·Status: UNKNOWN
-
Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
NCT06550427 ·Status: RECRUITING
-
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
NCT01553175 ·Status: COMPLETED
-
Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients with Metastatic Malignant Melanoma Treated with Targeted Therapies or Immunotherapy ( MALT )
NCT03493230 ·Status: COMPLETED ·Phase: NA
-
Comparison of Immune Response Following Surgical Management of Renal Tumors
NCT00289146 ·Status: TERMINATED
-
Prediction of True Oligo-metastatic Disease.
NCT05806151 ·Status: RECRUITING
-
Genetic Exploration of the Molecular Basis of Malignancy in Adults
NCT02416518 ·Status: COMPLETED
-
Use of Ctdna in Patients With Gastrointestinal Tract Tumors
NCT06202131 ·Status: RECRUITING
-
Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK Rearrangements
NCT02727335 ·Status: COMPLETED
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
Clinical Relevance of NGS Analysis for High-purity CTC From Cancer Patients With Disruptive Gene Mutation(s)
NCT03002350 ·Status: UNKNOWN
-
Rare CNS Tumors Outcomes &Risk
NCT03251989 ·Status: COMPLETED
-
CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
NCT04151342 ·Status: RECRUITING
-
Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer
NCT05285579 ·Status: UNKNOWN
-
Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells
NCT06194669 ·Status: RECRUITING
-
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
NCT06883565 ·Status: COMPLETED
-
Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes
NCT02355587 ·Status: TERMINATED
-
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
NCT05304858 ·Status: RECRUITING
-
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
NCT07019155 ·Status: RECRUITING